Target Healthcare REIT (LON:THRL) Given “Buy” Rating at Jefferies Financial Group

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating reiterated by equities research analysts at Jefferies Financial Group in a research report issued on Thursday, Digital Look reports. They currently have a GBX 124 price target on the stock. Jefferies Financial Group’s price objective would indicate a potential upside of 8.39% from the stock’s previous close.

Target Healthcare REIT Stock Down 0.2%

LON:THRL opened at GBX 114.40 on Thursday. The business’s 50-day simple moving average is GBX 111.92 and its two-hundred day simple moving average is GBX 109.21. Target Healthcare REIT has a 52 week low of GBX 92 and a 52 week high of GBX 117. The stock has a market cap of £709.55 million, a PE ratio of 8.59, a P/E/G ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT (LON:THRL) last released its quarterly earnings data on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. Sell-side analysts anticipate that Target Healthcare REIT will post 6.22 earnings per share for the current fiscal year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.